SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
233 hedge funds and large institutions have $306M invested in Sorrento Therapeutics, Inc. in 2022 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 87 increasing their positions, 37 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
233
Holders Change
+1
Holders Change %
+0.43%
% of All Funds
3.69%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
41
Increased
87
Reduced
37
Closed
37
Calls
$14.4M
Puts
$3.76M
Net Calls
+$10.7M
Net Calls Change
-$13.4M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$45.1M |
| 2 |
D.E. Shaw & Co
New York
|
+$11.2M |
| 3 |
Morgan Stanley
New York
|
+$5.52M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$3.86M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.8M |
Top Sellers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$10.2M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
-$1.74M |
| 3 |
Voloridge Investment Management
Jupiter,
Florida
|
-$786K |
| 4 |
Citigroup
New York
|
-$762K |
| 5 |
Barclays
London,
United Kingdom
|
-$760K |
